FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040678840> ?p ?o ?g. }

• W2040678840 endingPage "444" @default.
• W2040678840 startingPage "441" @default.
• W2040678840 abstract "Certain patients with silicosis have been reported to exhibit immunological abnormalities such as the appearance of antinuclear antibodies and the occurrence of autoimmune diseases. Fas ligand (FasL) is a type II membrane protein which induces apoptosis by binding to its membrane receptor, Fas. FasL is converted to a soluble form by a metalloproteinase-like enzyme. We have already found serum soluble Fas (sFas) levels in silicosis patients as well as in patients with systemic lupus erythematosus (SLE) to be significantly higher than those in healthy volunteers. To examine further the role of the Fas/FasL system in silica-induced immunological abnormalities, we investigated serum soluble FasL (sFasL) levels in silicosis patients with no clinical symptoms of autoimmune diseases, using ELISA for sFasL. Although the serum sFasL levels in patients with SLE were significantly higher than those in healthy volunteers and showed a slight positive correlation with serum sFas levels, those in silicosis patients exhibited no significant difference from those in healthy volunteers, and there was no correlation with serum sFas levels. However, sFasL levels were elevated in silicosis patients with slight dyspnoea or normal PCO2 among various clinical parameters of silicosis. It may be speculated that the immunological disturbances presented by the abnormalities of apoptosis-related molecules in silicosis patients do not occur with a similar degree of respiratory involvement. Further studies are required to clarify which kinds of factors are involved in silicosis patients who exhibit immunological abnormalities." @default.
• W2040678840 created "2016-06-24" @default.
• W2040678840 creator A5026814935 @default.
• W2040678840 creator A5028446128 @default.
• W2040678840 creator A5037687748 @default.
• W2040678840 creator A5042280275 @default.
• W2040678840 creator A5044079218 @default.
• W2040678840 creator A5048314148 @default.
• W2040678840 creator A5073261293 @default.
• W2040678840 creator A5090560877 @default.
• W2040678840 date "1999-12-01" @default.
• W2040678840 modified "2023-09-28" @default.
• W2040678840 title "Serum levels of soluble Fas ligand in patients with silicosis" @default.
• W2040678840 cites W1517945724 @default.
• W2040678840 cites W1577393853 @default.
• W2040678840 cites W1966331020 @default.
• W2040678840 cites W1973143853 @default.
• W2040678840 cites W1973792489 @default.
• W2040678840 cites W1992574424 @default.
• W2040678840 cites W1997296950 @default.
• W2040678840 cites W2002503549 @default.
• W2040678840 cites W2004647206 @default.
• W2040678840 cites W2015137197 @default.
• W2040678840 cites W2028111124 @default.
• W2040678840 cites W2038699165 @default.
• W2040678840 cites W2041466047 @default.
• W2040678840 cites W2046855003 @default.
• W2040678840 cites W2057332167 @default.
• W2040678840 cites W2064074285 @default.
• W2040678840 cites W2065413461 @default.
• W2040678840 cites W2084957243 @default.
• W2040678840 cites W2118017831 @default.
• W2040678840 cites W2139677775 @default.
• W2040678840 cites W2143996326 @default.
• W2040678840 cites W2164802863 @default.
• W2040678840 cites W2168336398 @default.
• W2040678840 cites W2319909416 @default.
• W2040678840 cites W2404748733 @default.
• W2040678840 cites W4247116838 @default.
• W2040678840 doi "https://doi.org/10.1046/j.1365-2249.1999.01083.x" @default.
• W2040678840 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1905452" @default.
• W2040678840 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10594565" @default.
• W2040678840 hasPublicationYear "1999" @default.
• W2040678840 type Work @default.
• W2040678840 sameAs 2040678840 @default.
• W2040678840 citedByCount "50" @default.
• W2040678840 countsByYear W20406788402012 @default.
• W2040678840 countsByYear W20406788402014 @default.
• W2040678840 countsByYear W20406788402016 @default.
• W2040678840 countsByYear W20406788402017 @default.
• W2040678840 countsByYear W20406788402019 @default.
• W2040678840 countsByYear W20406788402020 @default.
• W2040678840 crossrefType "journal-article" @default.
• W2040678840 hasAuthorship W2040678840A5026814935 @default.
• W2040678840 hasAuthorship W2040678840A5028446128 @default.
• W2040678840 hasAuthorship W2040678840A5037687748 @default.
• W2040678840 hasAuthorship W2040678840A5042280275 @default.
• W2040678840 hasAuthorship W2040678840A5044079218 @default.
• W2040678840 hasAuthorship W2040678840A5048314148 @default.
• W2040678840 hasAuthorship W2040678840A5073261293 @default.
• W2040678840 hasAuthorship W2040678840A5090560877 @default.
• W2040678840 hasBestOaLocation W20406788402 @default.
• W2040678840 hasConcept C126322002 @default.
• W2040678840 hasConcept C142724271 @default.
• W2040678840 hasConcept C149443304 @default.
• W2040678840 hasConcept C159654299 @default.
• W2040678840 hasConcept C163764329 @default.
• W2040678840 hasConcept C190283241 @default.
• W2040678840 hasConcept C203014093 @default.
• W2040678840 hasConcept C2776232647 @default.
• W2040678840 hasConcept C2777811718 @default.
• W2040678840 hasConcept C31573885 @default.
• W2040678840 hasConcept C55493867 @default.
• W2040678840 hasConcept C66008609 @default.
• W2040678840 hasConcept C71924100 @default.
• W2040678840 hasConcept C86803240 @default.
• W2040678840 hasConceptScore W2040678840C126322002 @default.
• W2040678840 hasConceptScore W2040678840C142724271 @default.
• W2040678840 hasConceptScore W2040678840C149443304 @default.
• W2040678840 hasConceptScore W2040678840C159654299 @default.
• W2040678840 hasConceptScore W2040678840C163764329 @default.
• W2040678840 hasConceptScore W2040678840C190283241 @default.
• W2040678840 hasConceptScore W2040678840C203014093 @default.
• W2040678840 hasConceptScore W2040678840C2776232647 @default.
• W2040678840 hasConceptScore W2040678840C2777811718 @default.
• W2040678840 hasConceptScore W2040678840C31573885 @default.
• W2040678840 hasConceptScore W2040678840C55493867 @default.
• W2040678840 hasConceptScore W2040678840C66008609 @default.
• W2040678840 hasConceptScore W2040678840C71924100 @default.
• W2040678840 hasConceptScore W2040678840C86803240 @default.
• W2040678840 hasIssue "3" @default.
• W2040678840 hasLocation W20406788401 @default.
• W2040678840 hasLocation W20406788402 @default.
• W2040678840 hasLocation W20406788403 @default.
• W2040678840 hasOpenAccess W2040678840 @default.
• W2040678840 hasPrimaryLocation W20406788401 @default.
• W2040678840 hasRelatedWork W1980206759 @default.
• W2040678840 hasRelatedWork W1985722893 @default.

• next